The results of an analytical review of practice by the Food and Drug Administration reveal a clear pattern of mistakes in their approval of Artificial Blood substitutes.<br />

Artificial Blood Substitutes Given Green Light Despite Clear Risks

Washington- The results of an analytical review of practice by the Food and Drug Administration reveal a clear pattern of mistakes in their approval of Artificial Blood substitutes.

Many of these approvals by the FDC were made even after there was clear and convincing evidence that the products in question were shown to cause death and heart failure.

The data that was examined was from more than 3,711 different patients who were participants in studies that tested different types of blood substitutes and artificial blood.

In 16 tests that were testing 5 different types of artificial blood the chance of dying was raised nearly 30 percent for anyone participating in the trial. This was clearly seen no matter what type of artificial blood substitute was being tested.

The study raises clear questions as why the FDC did not take action but instead was strangely silent despite all the clear and convincing evidence. There is a current study under review that appears to be like the others, raising risk to participants to a high and unacceptable level.

“This is just hard to comprehend,” said Charles Natanson. Dr. Natanson is a senior member of the investigating team headed by the National Institute of Health.

Despite this new information, the new proposed study has not been pulled from consideration, and the FDA has yet to respond as to its decision.

An ongoing investigation continues, and the FDA will have to defend its actions.